[Current status of HIV vaccine development]

Area of Science:

• Immunology
• Virology
• Vaccinology

Context:

• Developing effective HIV vaccines remains a significant global health challenge.
• T-cell responses are a primary focus for HIV vaccine strategies.
• The role of T-cell responses in achieving sustained HIV control is not fully understood.

Purpose:

• To investigate the role of cytotoxic T lymphocytes (CTLs) in controlling HIV replication.
• To determine which T-cell responses are most effective for primary HIV control.
• To analyze viral polymorphisms induced by CTLs to identify effective immune responses.

Summary:

• While many HIV vaccine candidates aim to induce virus-specific T-cell responses, their efficacy in controlling the virus is uncertain.
• Recent studies in macaque models suggest that inducing potent cytotoxic T lymphocytes (CTLs) can lead to viral containment.
• CTLs that strongly suppress viral replication often drive the selection of viral escape mutations, impacting viral fitness.

Impact:

• Identifying effective CTL responses is critical for designing future HIV vaccines.
• Understanding CTL-induced viral evolution can inform strategies to overcome viral escape.
• This research contributes to the ongoing effort to develop a functional HIV vaccine for global health.
• The findings highlight the potential of CTL-based vaccines for achieving durable HIV control.